Maze Therapeutics, Inc.
MAZE
$27.18
-$0.49-1.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -133.59M | -122.54M | -131.12M | -126.13M | -120.80M |
| Total Depreciation and Amortization | 1.91M | 2.16M | 2.40M | 2.61M | 2.83M |
| Total Amortization of Deferred Charges | 498.00K | 371.00K | -- | -- | -- |
| Total Other Non-Cash Items | 29.02M | 23.00M | 19.05M | 17.79M | 19.41M |
| Change in Net Operating Assets | -4.37M | -24.52M | -2.27M | -931.00K | -6.66M |
| Cash from Operations | -106.54M | -121.54M | -111.94M | -106.66M | -105.23M |
| Capital Expenditure | -302.00K | -588.00K | -794.00K | -1.37M | -1.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -292.20M | -163.80M | -170.17M | -66.82M | -- |
| Cash from Investing | -292.50M | -164.39M | -170.96M | -68.18M | -1.40M |
| Total Debt Issued | 39.40M | 39.40M | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 299.78M | 154.49M | 278.29M | 274.76M | 131.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 70.79M | 70.79M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.04M | -3.57M | -2.95M | -3.54M | -5.92M |
| Cash from Financing | 337.14M | 190.32M | 275.34M | 342.01M | 196.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.90M | -95.61M | -7.57M | 167.17M | 89.48M |